Huahlan Bioengineering Chongqing Co., Ltd. Production Process

1. Introduction

Huahlan Bioengineering Chongqing Co., Ltd. is a subsidiary of Huahlan Bioengineering Co., Ltd., which is the only blood product production enterprise in Chongqing and the largest blood product production enterprise in China. It was established in August 2007 and has been in operation for 16 years and 5 months. The company is involved in the research, development, production, and sales of blood products, vaccines, and recombinant proteins.

2. ISO Management Certification

Huahlan Bioengineering Chongqing Co., Ltd. has obtained comprehensive ISO management system certifications in quality, environment, and occupational health and safety. This demonstrates the company's commitment to maintaining high standards in these areas.

3. Independent Intellectual Property Rights

The company holds multiple independent intellectual property rights in the field of biotechnology. These rights are a testament to the company's innovative capabilities and contribute to its leading position in the market.

4. Product Portfolio

The main products of Huahlan Bioengineering Chongqing Co., Ltd. include human albumin, human immunoglobulin, and other blood products. These products have a significant production scale, market share, and brand recognition, making them highly competitive in the industry.

5. Company Profile

Company Type: Joint-stock enterprise

Company Size: 100-499 employees

Industry: Pharmaceutical/Biotechnology

Huahlan Bioengineering Chongqing Co., Ltd. is dedicated to the research, development, and production of blood products and bacterial vaccines. As a national-level high-tech enterprise and an innovative pilot enterprise, the company has played a crucial role in advancing the field of biotechnology.

6. Production and Research Focus

Huahlan Bioengineering Chongqing Co., Ltd. primarily focuses on the production and research of blood products. The company's employees, consisting of 295 males and 273 females, are engaged in various activities related to the production, development, and sales of blood products.

7. Product Details

Product Name: Human Albumin

Approval Number: National Medical Products Administration Approval No. S20143012

Composition: Each 1.0ml injection contains at least 10g total protein, with a minimum of 96% human albumin sodium (0.17g or 7.5m)

Production Enterprise: Huahlan Bioengineering Chongqing Co., Ltd.

8. Application of Products

Indication 1: Hypovolemic shock caused by bleeding or burns, shock in pediatric patients.

Indication 2: Increased intracranial pressure caused by brain edema or injury.

Indication 3: Elevated intracranial pressure caused by liver cirrhosis.

9. Job Requirements at Huahlan Bioengineering Chongqing Co., Ltd.

To apply to Huahlan Bioengineering Chongqing Co., Ltd., candidates are expected to have a comprehensive understanding of the company and be familiar with all the processes involved in drug development. During the interview process, candidates are required to submit their graduation certificates, degree certificates, resumes, identification cards, and relevant qualification certificates as proof of their qualifications.

In conclusion, Huahlan Bioengineering Chongqing Co., Ltd. is a leading biotechnology company in China, specializing in the production of blood products and vaccines. With its ISO management certifications, independent intellectual property rights, and high-quality products, the company has established a strong presence in the market.